Research Article: Exploring the Expression and Prognosis of Mismatch Repair Proteins and PD-L in Colorectal Cancer in a Chinese Cohort
Introduction:
There has been significant progress in cancer care over the last several decades. This progress has allowed scholars to make significant breakthroughs in understanding the tumor immune response. As a result, the application of immunotherapy and immune checkpoint inhibitors (ICPIs) has rapidly become a viable direction in cancer treatment for patients in the clinic. , Germani et al recently demonstrated that patients with colorectal cancer who express high levels of microsatellite instability (MSI-H)/mismatch…
Read more